Literature DB >> 24823444

Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively: results of a prospective multicenter study.

Claire Blanchard1, Muriel Mathonnet, Frédéric Sebag, Cécile Caillard, Caroline Kubis, Delphine Drui, Elise van Nuvel, Catherine Ansquer, Jean-François Henry, Damien Masson, Françoise Kraeber-Bodéré, Jean-Benoît Hardouin, Rasa Zarnegar, Antoine Hamy, Eric Mirallié.   

Abstract

BACKGROUND: The objectives of this study were to evaluate, in mild primary hyperparathyroidism (pHPT) patients, the quality of life (QoL) using the SF-36 questionnaire before and after parathyroidectomy and to detect preoperatively patients who benefit the most from surgery. Most pHPT patients present a mild pHPT defined by calcemia ≤11.4 mg/dL. For these patients, there is debate about whether they should be managed with surveillance, medical therapy, or surgery.
METHODS: A prospective multicenter study investigated QoL (SF-36) in patients with mild pHPT before and after parathyroidectomy in four university hospitals. Laboratory results and SF-36 scores were obtained preoperatively and postoperatively (3, 6, and 12 months).
RESULTS: One hundred sixteen patients were included. After surgery, the biochemical cure rate was 98%. Preoperatively, the mental component summary and the physical component summary (PCS) were 38.69 of 100 and 39.53 of 100, respectively. At 1 year, the MCS and the PCS were 41.29 of 100 and 42.03 of 100. The subgroup analysis showed a more significant improvement in patients < 70 years and with calcemia ≥10.4 mg/dL. Postoperative PCS was correlated with age and preoperative PCS: variation = 32.11 - 0.21 × age - 0.4 × preoperative PCS. Men did not improve their MCS postoperatively. Only women with a preoperative MCS <43.6 of 100 showed postoperative improvement.
CONCLUSIONS: This study showed, in patients with mild pHPT, an improvement of QoL 1 year after parathyroidectomy. Patients <70 years and with calcemia ≥10.4 mg/dL had a more significant improvement.

Entities:  

Mesh:

Year:  2014        PMID: 24823444     DOI: 10.1245/s10434-014-3731-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  5 in total

Review 1.  Primary hyperparathyroidism.

Authors:  John P Bilezikian; Natalie E Cusano; Aliya A Khan; Jian-Min Liu; Claudio Marcocci; Francisco Bandeira
Journal:  Nat Rev Dis Primers       Date:  2016-05-19       Impact factor: 52.329

2.  The impact of patient age on practice patterns and outcomes for primary hyperparathyroidism.

Authors:  Whitney Sutton; Joseph K Canner; Jessica B Shank; Abbey L Fingeret; Shkala Karzai; Dorry L Segev; Jason D Prescott; Aarti Mathur
Journal:  Am J Surg       Date:  2022-03-19       Impact factor: 3.125

3.  Health-related quality of life is impaired in primary hyperparathyroidism and significantly improves after surgery: a prospective study using the 15D instrument.

Authors:  Eeva M Ryhänen; Ilkka Heiskanen; Harri Sintonen; Matti J Välimäki; Risto P Roine; Camilla Schalin-Jäntti
Journal:  Endocr Connect       Date:  2015-07-08       Impact factor: 3.335

4.  Symptoms of Primary Hyperparathyroidism in Men and Women: The Same but Different?

Authors:  Theresia Weber; Andreas Hillenbrand; Simon Peth; Rainer Hummel
Journal:  Visc Med       Date:  2020-01-22

Review 5.  Physical Activity-Dependent Regulation of Parathyroid Hormone and Calcium-Phosphorous Metabolism.

Authors:  Giovanni Lombardi; Ewa Ziemann; Giuseppe Banfi; Sabrina Corbetta
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.